Advanced Medical Solutions Group (LON:AMS) Shares Cross Above 200-Day Moving Average – Here’s What Happened

Shares of Advanced Medical Solutions Group plc (LON:AMS) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 208.49 and traded as high as GBX 216.50. Advanced Medical Solutions Group shares last traded at GBX 212.50, with a volume of 2,377,734 shares.

Analyst Ratings Changes

A number of research analysts have recently issued reports on AMS shares. Berenberg Bank reiterated a “buy” rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Peel Hunt restated a “buy” rating and set a GBX 246 price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of GBX 273.67.

Advanced Medical Solutions Group Price Performance

The firm has a market cap of £459.55 million, a PE ratio of 50.96, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The stock’s fifty day moving average price is GBX 217.12 and its 200-day moving average price is GBX 208.65. The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58.

Advanced Medical Solutions Group (LON:AMS) last posted its quarterly earnings results on Wednesday, September 17th. The company reported GBX 5.77 earnings per share for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. As a group, equities analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Eddie Johnson sold 18,726 shares of the business’s stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of GBX 220, for a total transaction of £41,197.20. Also, insider A Christopher (Chris) Meredith sold 50,510 shares of the company’s stock in a transaction that occurred on Wednesday, September 24th. The shares were sold at an average price of GBX 218, for a total value of £110,111.80. Company insiders own 4.12% of the company’s stock.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.